mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis
mSEP: Investigation of Maternal Immunity and Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis
1 other identifier
observational
330
1 country
1
Brief Summary
A prospective observational cohort study investigating physiological parameters vs biological markers of whole blood in septic and non-septic pregnant woman to predict systemic immune health
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2020
CompletedFirst Submitted
Initial submission to the registry
August 10, 2021
CompletedFirst Posted
Study publicly available on registry
August 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedAugust 27, 2021
August 1, 2021
1.5 years
August 10, 2021
August 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Positive predictive value of genomic sepsis-test biomarker in identifying participants with confirmed sepsis
New genomic sepsis-test biomarker tested to see if it compares to clinically known biomarkers in identifying sepsis
2 years
Study Arms (2)
A
A longitudinal observational study looking at the pregnancy journey of 200 women Bloods taken for sepsis biomarkers including a genomic sepsis-test throughout the pregnancy journey
B
A consecutive collection of data from 100 pregnant women with suspected sepsis Bloods taken for Sepsis Biomarkers including a genomic sepsis-test throughout the sepsis episode
Interventions
Eligibility Criteria
Pregnant women attending University Hospital of Wales Cardiff for their pregnancy care
You may qualify if:
- Pregnant with viable pregnancy confirmed on ultrasound at dating scan and over 18 years of age Able to provide informed consent (a translation service will be provided for women where English is not the first language);
- Women recruited into Cohort B will have deferred consent taken to avoid interference with clinical care.
You may not qualify if:
- Pregnant woman under the age of 18 or wishing not to consent, withdrawing consent or lacking capacity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cardiff Universitylead
- Cardiff and Vale University Health Boardcollaborator
Study Sites (1)
Sir Geraint Evans, Cardiff University
Cardiff, CF14 4ED, United Kingdom
Related Publications (1)
Sharma S, Zaher S, Rodrigues PRS, Davies LC, Edkins S, Strang A, Chakraborty M, Watkins WJ, Andrews R, Parkinson E, Angelopoulos N, Moet L, Shepherd F, Davies KMM, White D, Oram S, Siddall K, Keeping V, Simpson K, Faggian F, Bray M, Bertorelli C, Bell S, Collis RE, McLaren JE, Labeta M, O'Donnell VB, Ghazal P. mSep: investigating physiological and immune-metabolic biomarkers in septic and healthy pregnant women to predict feto-maternal immune health - a prospective observational cohort study protocol. BMJ Open. 2022 Sep 17;12(9):e066382. doi: 10.1136/bmjopen-2022-066382.
PMID: 36115679DERIVED
Biospecimen
RNA analysis
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Ghazal, PHD
Cardiff University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2021
First Posted
August 27, 2021
Study Start
October 12, 2020
Primary Completion
April 1, 2022
Study Completion
September 1, 2022
Last Updated
August 27, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share